3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Head & Neck
1
Breast
1
Conditions
Obesity
1
Inflammation
1
Breast Neoplasms
1
Interventions
Tirzepatide
5
Educational Status
4
Methods
3
Interviews as Topic
3
Early Intervention, Educational
3
semaglutide
2
naldemedine
2
Standard of Care
2
Specimen Handling
2
Radiotherapy
2
Paclitaxel
2
Observation
2
Mouthwashes
2
Metformin
2
Exercise
2
Counseling
2
Cisplatin
2
Carboplatin
2
trametinib
1
tempol
1
sotorasib
1
selpercatinib
1
polyethylene glycol 3350
1
pembrolizumab
1
osimertinib
1
naloxegol
1
mirabegron
1
maltodextrin
1
ma zi ren wan
1
lorlatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Pregabalin
×
Other
×
Clear all
NCT06150898
2025-06-13
KePreSt
Jules Bordet Institute
Phase 2
Recruiting
112 enrolled